Pharma Focus Asia

Thermo Fisher Scientific Collaborates with Arsenal Biosciences

Thursday, March 30, 2023

Thermo Fisher Scientific and Arsenal Biosciences announced an update to the strategic collaboration to further the development of manufacturing processes for new cancer treatments. This research and process development-focused collaboration has enabled ArsenalBio to develop a robust manufacturing process for their next-generation, programmable autologous T cells for the treatment of cancer.

By partnering with ArsenalBio as a pioneer in T-cell therapy for solid tumours, helps to provide more options who are most in need of innovative treatments. This collaborative cell therapy programme, enables the industry to move from reactive to proactive, leverage biological and technical expertise to improve the economics of therapeutic production, and move towards expanded access to patients worldwide.

This partnership with Thermo Fisher allows to combine targeted solutions and expertise with the team's innovative approach to clinical trials and processing capabilities to manufacture ArsenalBio products and explore future therapeutic innovations.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024